Scienture Holdings - SCNX Enterprise Value-to-Revenue Multiple

Scienture (SCNX) - corporate logo

The growth of Scienture Holdings Inc (SCNX) is driven by the TRxADE B2B platform for drug procurement and the development of CNS medications. The company's price-to-sales trajectory confirms this potential, where 16292.31 describes the current status of the metric. Sustainability through telemedicine and the integration of digital tools into clinical trials create a favorable external environment for further business scaling.

Scienture Corp - SCNX EV/Sales Multiple (period 11/23/2025 - 11/20/2026)

SCNX (Scienture Holdings Inc.): analytical breakdowns and indicator data

- cash and cash flow indicators:
Fundamental company valuation:Scienture Holdings Inc, SCNX
Core merchandise of Scienture Holdings

The digitalization trends in clinical trials and contracts with Big Pharma are reflected in the business valuation of Scienture Holdings Inc (SCNX) via the EV/Sales multiple, which currently stands at 16292.31. This indicator correlates the total enterprise value (market capitalization and net debt) with annual revenue, allowing investors to assess the real value of assets regardless of debt load and timely identify risks of the asset being overbought.

Competitor analysis for Scienture Holdings Inc

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|Certara Inc - Company Value to Revenue|OMCL - Company Value to Revenue|GDRX - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Schrodinger Corp SDGR|PHR: EV/Sales Multiple|OMDA - Total Company Value-to-Revenue Ratio|EVH (Evolent Health Inc) - EV/Sales Multiple|Company Value to Revenue Ratio HSTM (HealthStream)|EV/Sales Multiple DH|CCSI (Consensus Corp) - Business Value to Revenue|agilon health Inc - Company Value to Revenue|absci.com - Enterprise Value-to-Revenue Ratio|SY - Enterprise Value-to-Revenue Ratio|Business Value to Revenue NRC (National Research)|USA Mobility (SPOK) - Enterprise Value-to-Revenue Ratio|OPRX: Enterprise Value-to-Revenue Coefficient|Company Value to Revenue TBRG|simulations-plus.com (SLP) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio sophiagenetics.com (SOPH)|HCAT (Health Catalyst) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio CareCloud, Inc. CCLD|Total Company Value-to-Revenue Ratio Research Solutions (RSSS)|DLH Corp - EV/Sales Multiple|ONMD (OneMedNet) - Company Value to Revenue Ratio|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)